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Occult Adenocarcinoma Presenting as Presumed Periorbital Cellulitis
Abstract
Background: Orbital tumors are uncommon entities seen by optometrists. They may initially present as
common, benign conditions, but if not appropriately diagnosed can lead to devastating results.
Case Report: This case report demonstrates an atypical presentation of adenocarcinoma that was initially
diagnosed as preseptal cellulitis. The patient in this case was ultimately referred for imaging and biopsy
to reveal the correct diagnosis. Despite treatment, this patient died about 1 year after his clinical
presentation.
Conclusion: The detection of orbital tumors and the subsequent management of patients with orbital
tumors can be challenging. When considering orbital tumors as a possible diagnosis, careful examination
is necessary to identify key clinical characteristics and to assist with ordering the appropriate imaging
studies. Identifying these critical findings will allow an eye care provider to make a timely and appropriate
referral for continued management of the patient.
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BACKGROUND
Orbital tumors are uncommon entities seen by optometrists. They may initially
present as common, benign conditions, but if not appropriately diagnosed can lead
to devastating results.
CASE REPORT
A 67-year-old Caucasian male presented to the eye clinic for follow-up regarding
left eyelid redness and swelling. His initial exam findings one month prior, included
visual acuities of 20/25 right eye (OD) and 20/25 left eye (OS), with pupils and
extraocular motilities being described as unremarkable. Past medical history was
significant for hypertension for which he was taking lisinopril 20 mg daily, and
environmental allergies for which he was taking loratadine 10 mg daily. Initially,
he was diagnosed with preseptal cellulitis and was started on amoxicillin/clavulanic
acid 500 mg by mouth, three times daily for ten days.
At his follow up visit his entering corrected distance visual acuities were 20/30
OD and 20/80 OS, without any improvement with pinhole. Pupils were equal,
round, reactive to light (4 2mm OD and OS) without relative afferent pupillary
defect. Ocular alignment appeared grossly orthophoric in primary gaze, while
ocular motility was restricted, left eye greater than right (Figure 1).
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Figure 1: Extraocular motility findings at presentation. The right eye shows moderate EOM

Published by The Athenaeum, 2022

67

Optometric Clinical Practice, Vol. 4 [2022], Iss. 2, Art. 6

restriction in supraduction and mild restriction in adduction. The left eye shows moderate-severe
restriction in supraduction, mild restriction in abduction and moderate restriction in infraduction.
Figure 2: External photograph demonstrating periorbital swelling and erythema, left eye
greater than right. The patient also displays significant matting of the eyelashes mostly
with the left eye.

External examination of the patient was significant for periorbital swelling and
erythema, left eye greater than right, both upper and lower lids, with the left eye
shut (Figure 2). There was crusting along the eyelashes, left eye greater than right,
as well. Palpation of the eyelids revealed firm, nodular masses of the upper and
lower lids, worse in the left eye, and without pain or discomfort. Significant
pressure was needed to open the eye (even the slightest) to evaluate EOM and pupil
function. Margin to reflex distance (MRD1) was 0 in the right eye and roughly 5mm left eye. Further ancillary testing, including exophthalmometry, proved to be
difficult because of significant eyelid involvement. Anterior segment showed
significant tear film debris, left eye more than right, but the conjunctiva and anterior
chamber appeared quiet, and the cornea and irides were of normal appearance.
Intraocular pressures were 15 mm Hg in the right eye and 17 mm Hg in the left eye
with a tonopen. Upon dilation, the patient’s crystalline lens showed very mild
nuclear sclerosis in both eyes, not likely contributing to the patients reduced vision.
A dilated examination of the posterior pole was normal in both eyes, although the
left eye was extremely difficult to assess. Given the unremarkable pupils and a
grossly normal posterior pole, it was postulated that the patient’s reduced vision in
the left eye was due to possible tear film abnormalities and/or corneal distortion
due to lid infiltration causing compression of the cornea.
An oculoplastic specialist was also consulted on the same day for evaluation, and
a computed tomography (CT) of head and orbits, with and without contrast, was
completed within 48 hours. The radiology report showed bilateral homogenously
enhancing pre- and post-septal orbital masses involving the medial canthus and
lacrimal glands, the largest lesion measuring 2 cm x 4 cm. Abnormal enhancement
of the superior, medial, and inferior rectus was present bilaterally. Figures 3 and 4
show some of the extent of infiltration into periorbital tissue. Optic nerves appeared
within normal limits. Enlarged lymph nodes measuring 1.5 cm in size were also
noted on the left side. T h e impression given by the radiologist was consistent
with a neoplastic process involving the orbits, glands, and cervical lymph nodes.
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Figure 3: CT scan showing left sided medial rectus infiltration (red arrow), along with periorbital
softtissue thickening (yellow arrow). This scan also shows mild proptosis of the left eye, although
overaccentuated due to head rotation and lid tissue thickening.

Figure 4: CT scan showing periorbital soft tissue involvement left eye (red arrow) more than
right (yellow arrow).

The radiology report concluded that the findings from the CT were most
concerning for a neoplastic condition such as lymphoma, but they could not rule
out a granulomatous condition.

Published by The Athenaeum, 2022

69

Optometric Clinical Practice, Vol. 4 [2022], Iss. 2, Art. 6

One week later, the patient underwent an incisional biopsy of the left orbital mass
as well as a left lateral canthotomy and inferior cantholysis. The pathology analysis
was most consistent with adenocarcinoma. Further evaluation with
immunohistochemical staining (IHC) ruled out evidence of a pulmonary or
gastrointestinal primary tumor, therefore it was determined to be an
adenocarcinoma of unknown etiology, most likely originating from the lacrimal
gland.
An oncologist was consulted for further testing and management. The patient was
scheduled for magnetic resonance imaging (MRI) of the brain, orbits, and neck,
with and without contrast, as well as a positron emission tomography (PET) scan.
The MRI displayed bilateral orbital masses with extension, surrounding the left
optic nerve (Figure 5). Figure 6 displays the significant degree of EOM
involvement in the left eye, while Figure 7 shows a possible affected lymph node.
The cavernous sinus appeared intact and unremarkable. PET scan showed multiple
small, enhancing foci present in the brain as well as lesions within the spine (Figure
8) and left sided lymph node (Figure 9) which was concerning for metastases. (Both
figures 8 and 9 are PET only MIP (maximum intensity projection) 3D images that
are relatively low-resolution images but are highly sensitive to activity. Higher
resolution is possible but wouldn’t capture the extent of activity displayed on the
3D image. While PET images are great for visualizing activity, their resolution is
never as high as CT or MRI images.)

Figure 5: MRI showing significant medial rectus thickening (red arrow) compared to the other
extraocular muscles. Also displayed is the tumor extension in the retrobulbar space, surrounding
the optic nerve of the left eye (yellow arrow).
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Figure 6: MRI displaying significant asymmetry of EOM involvement. Inferior (red
arrow) and medialrectus (yellow arrow) of the left eye were thickened compared to the
right eye.

Figure 7: MRI displaying left sided enlarged enhancing jugular lymph node (red star).
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Figure 8: PET scan showing normal uptake within the kidneys and bladder (red stars). Also noted
aremultiple areas (yellow stars) of activity within the vertebrae, sternum, and other boney structures,
displaying significant metastases.

Figure 9: PET scan showing activity within the left side lymph node (red star), demonstrating
metastases that corresponds to enlarged lymph node on MRI.
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Since there was metastasis to the brain, bone, cervical, and possibly axillary lymph
adenopathy, palliative chemotherapy was the mode of treatment. The goal was to
alleviate the deterioration of vision, pain, and central nervous system (CNS)
progression. Even though it would have been beneficial to re- evaluate the patient
after management from oncology and ophthalmology, the patient was placed in
hospice and declined any further follow up eye care. The patient subsequently
passed away about a year after the initial eye visit.
DISCUSSION
There are several conditions to consider when a patient presents with swollen
eyelids. Clinical evaluation and testing should guide the practitioner to an
appropriate differential diagnosis. In this case, the patient initially presented with
unilateral eyelid edema and erythema. A diagnosis of preseptal cellulitis was given
and the patient was started on oral antibiotics. The patient returned to clinic after
he failed antibiotic therapy, with additional involvement bilaterally.
When a patient presents with orbital involvement, manifest by motility restriction
in both eyes, as with our patient, a physical examination should be thorough to
help direct additional testing necessary for proper and timely diagnosis.
Examination should include visual acuity, color vision testing, pupillary function
testing, exophthalmometry, ocular motility testing, visual field testing, intraocular
pressures, and a dilated fundus exam. Additionally, palpation for resistance to
retropulsion can be beneficial when suspicious for an orbital mass. Finally,
neuroimaging of the orbits is critical to determine the presence, extent, and cause
of orbital involvement.
When considering cellulitis as a diagnosis, it is important to distinguish between
preseptal cellulitis and orbital cellulitis for adequate and prompt treatment. Orbital
cellulitis, an emergent condition, should be ruled out when a patient presents with
a red swollen eye, orbital pain, and double vision. Some signs might include ocular
motility restriction, proptosis, chemosis, or reduced vision with optic nerve
involvement. A careful case history should include questions regarding recent
history of an upper respiratory infection, sinus infection, fever and malaise.
Although more likely unilateral, orbital cellulitis should be considered on the list
of differential diagnoses for bilateral orbital swelling, along with inflammatory
causes (i.e., thyroid eye disease and idiopathic orbital inflammatory syndrome) and
infiltrative causes (i.e., lymphoma, sarcoidosis, and other metastatic disease). Since
imaging studies will usually display concomitant sinus disease, ENT experts need
to be consulted as well for possible surgical intervention. If not sent for immediate
evaluation and management, orbital cellulitis can lead to further complications like
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cavernous sinus thrombosis, meningitis, or cerebral abscess. Patients with a number
of oncologic conditions are prone to cellulitis, for example patients with leukemia.
Certain types of patients, usually those with diabetes mellitus or who are
immunocompromised, may develop a cellulitis with mucormycosis, a fungus which
is an inexorably progressive condition that needs rapid diagnosis to prevent death.
Aspergillosis is another serious cause of fungal orbital cellulitis in predisposed
cases.
Thyroid eye disease (TED) is an autoimmune condition where orbital involvement
may present with all or some of the following: pain with or without eye movement,
lid swelling and erythema, conjunctival redness and, chemosis, and
caruncle/semilunar fold swelling and erythema, eye lid retraction, diplopia, and
proptosis. In severe cases, progressive swelling can even lead to vision loss due to
compression on the optic nerve, which is a medical emergency. Thyroid function
testing, including thyroid stimulating hormone (TSH), triiodothyronine (T3) and
thyroxine (T4) are helpful when ruling out thyroid eye disease (TED), but thyroidstimulating immunoglobulin (TSI) is one of the better tests to prove the diagnosis
is likely thyroid eye disease. CT imaging in patients with TED displays the
characteristic finding of enlargement of the extraocular muscle bellies with sparing
of the tendons.1 A referral of patients to an oculoplastic specialist is important as
there is now a new drug (teprotumumab), a monoclonal antibody, that is effective
in the treatment of this condition when in the active state.2
Idiopathic orbital inflammatory syndrome (IOIS), or orbital pseudotumor, should
also be considered when a patient presents with a rapid onset of orbital pain and
swelling. Restriction of extraocular movements and chemosis are also some likely
exhibited signs. Orbital imaging studies, like CT, may show inflammation of the
lacrimal gland, extraocular muscles and tendons, orbital fat, and sclera. IOIS, which
is also usually unilateral, is a diagnosis of exclusion when infection, systemic
inflammatory disease and neoplasms are ruled out. The condition may be associated
with rheumatic conditions.3 Also, IgG4 is another systemic condition that is
associated with orbital inflammation, but it is a syndrome of its own that has CNS
as well as systemic signs. Therefore, these types of patients should be referred to
orbital experts (because sometimes biopsies are necessary) and rheumatologists.
Sarcoidosis is a systemic granulomatosis process that commonly occurs in the
second to fourth decade of life. It may present as palpable periocular lesions and
can affect the lacrimal gland and orbit as well as most ocular structures, like in the
presented case. It is important to look for intra-ocular inflammation since uveitis is
the most common ocular manifestation of sarcoidosis.4 Careful evaluation of the
anterior chamber for cell and flare, as well as a dilated fundus examination to rule
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out posterior uveitis is necessary. A chest x-ray and serum ACE testing should be
considered in cases of suspected sarcoidosis.
Orbital lymphoma is the most prevalent orbital neoplasm that can affect the orbit,
lacrimal gland, and eyelids with a similar presentation as in this patient. CT and
MRI imaging of a lymphoma will display a well-defined orbital mass that molds to
adjacent orbital structures without bony destruction.5 In cases of a suspected
lymphoma or other orbital tumors, a biopsy is necessary for further identification.
Other oncologic conditions that may metastasize to the orbit include, but are not
limited to, breast and melanoma.
When considering an orbital tumor as a differential diagnosis, it is important to
look for common signs and symptoms that would increase suspicion. In one
retrospective review of 200 patients age 60 years or older with orbital tumors, the
main clinical features were palpable or visualized masses (26%), proptosis (18%)
and pain (15%). Visual acuity in these patients may range from not being affected
to no light perception (NLP) with around 76% presenting with visual acuity better
than 20/50.6 An additional review of 100 patients with orbital metastasis found the
most frequent clinical findings to be limited ocular motility (54%), proptosis (50%)
and palpable mass (43%).7
Orbital tumors can be benign or malignant in nature. Malignant tumors are further
classified into primary, secondary, and metastatic tumors. Primary tumors originate
from the orbital tissue itself. A secondary tumor of the orbit arises from adjacent
tissue, such as the eyelid or uveal track. Finally, a metastatic tumor is a lesion which
arises from a remote location, such as the liver. Current literature indicates that the
most common primary malignant tumor is lymphoma, and the most common
secondary malignant tumor was of conjunctival and intraocular orgin.6,8 The most
common benign primary tumor was a cavernous hemangioma and the most
common metastatic orbital tumors were from breast and prostate cancers. 6,8 The
types and frequencies of orbital tumors varies highly in the literature based on the
source of information. In a report from Hakan et. al, the orbital tumor was malignant
in 63% and benign in 27% of lesions surveyed.6 Of the 1264 patients reviewed by
Shields et al, 64% of the lesions were benign while 36% were malignant.8 The
Shields paper included patients of varying ages, while Hakan included patients
older than age 60. There is limited information in the literature about the spectrum
of orbital tumors in the senior adult population aged 60 years or older.6
Adenocarcinoma is a type of cancer associated with mucus secreting glands
located throughout the body. The most common sites of origin are the hepatobiliary
tree (comprised of the gallbladder, liver, and bile ducts), the lung, and the
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pancreas.9,10 The initial diagnosis and tumor subtype should be made with light
microscopy, but further labs, imaging and tissue studies are usually needed to fully
assess the lesion and the possibility of metastasis. As with this patient, if there is no
known primary tumor site determined it is considered a cancer of unknown primary
(CUP), which makes up for about 3-5% of all cancers.11,12 About 70% of CUPs are
adenocarcinomas and the prognosis for these patients is poor due to extensive
metastases, most commonly extending to the liver, lungs, lymph nodes, and bones.9
Interestingly, lymph node involvement can be an indicator of survival time. A
twelve-month survival rate was 17% for those displaying extranodal characteristics
compared to 41% whose adenocarcinoma was limited to the lymph nodes. The
mean survival times were 3 and 8 months respectively.13
Different imaging modalities can be very useful when trying to identify possible
orbital pathology. These modalities include ultrasonography, color Doppler
imaging, computed tomography (CT) and magnetic resonance imaging (MRI).14
Ultrasound imaging is non-invasive, safe, fast and can help to detect lesions before
deciding on further imaging with CT or MRI. Ultrasound imaging is, however,
limited to more anterior located lesions. Color Doppler imaging is beneficial for
differentiating between normal orbital vasculature and tumor vascularization. The
two most important modalities in orbital imaging are CT and MRI. CT imaging is
widely available, relatively inexpensive, and images can be acquired quickly. CT
images are often ordered in emergent situations, such as acute hemorrhage, orbital
or ocular trauma, and when an MRI is unavailable or contraindicated. CT gives
excellent visualization of the orbital bones, lacrimal drainage system and possible
calcified lesions. When ordering CT scans, it is recommended that contrast be
ordered, unless the patient has iodine contrast allergy or renal failure. The use of
contrast improves the sensitivity and specificity of the CT scan interpretation.15 In
contrast, MRI is more expensive, has longer acquisition time, and is not as widely
available compared to CT imaging. However, when available, MRI is generally the
imaging modality of choice when imaging the orbits. An MRI is able to image soft
tissue of the orbit, the optic nerves and the orbital apex well. MR images can either
be T1 weighted, which better identifies normal structures, or T2 weighted, which
better identifies pathology. Generally, the provider ordering the MRI does not need
to specify T1 and T2 as they are both done routinely with an MRI of the orbits or
brain. Fat suppression should be included in a provider’s imaging order for MRI,
as it allows for better interpretation of pathology while suppressing the bright signal
of normal fat tissue.15 Potential contraindications for MRI would include the
presence of medical implants, such as a cardiac pacemaker or extreme
claustrophobia.
Improved understanding of these lesions due to utilization of
immunohistochemical (IHC) staining and molecular cancer classifying assays
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(MCCAs) has led to more targeted and effective therapies. IHC analysis, used in
our patient, is a technique that uses stains on biopsied tissue to look for target
proteins that can help determine a tumor’s site of origin. It can be difficult when
deciding which specific markers to test for due to the limited amount of excised
tumor tissue and time constraints to make a diagnosis. In certain situations, specific
markers can lead a clinician toward a primary site diagnosis allowing them to create
a more precise site-specific therapy and lessen the toxicity for the patient.
Unfortunately, IHC correctly identifies less than 30% of CUPs, making
management more difficult for these patients.12 A small percentage of patients with
cancer of unknown primary may benefit from resection or more targeted therapy,
but unfortunately the majority rely on empiric chemotherapy. Historically, average
life expectancy for someone with adenocarcinoma of unknown primary is around
4-6 months, but with improved methods of classification and more precise treatment
modalities, that number is expected to be greater.9
When examining patients, it is important to carefully consider the findings and the
patient’s symptoms to make sure they correspond to an appropriate diagnosis. Lid
erythema and swelling can be a manifestation of various conditions such as
hordeolum, preseptal and orbital cellulitis, contact dermatitis, inflammation, or
tumors. While this patient did display some signs of preseptal cellulitis, the bilateral
nature, absence of inflammatory signs, restriction of the extraocular muscles, and
poor response to oral antibiotics suggested an alternative diagnoses for
consideration. This case is unusual as it presented as a preseptal cellulitis, with
evolution into a bilateral infiltrative orbitopathy with massive lid, lacrimal, and
orbital muscle tumor invasion. This was likely metastatic from the lacrimal gland,
but this was not definite and could therefore be classified as an unknown primary
adenocarcinoma metastatic to both orbits, lymph nodes and bones. As clinicians,
determining when to order imaging studies can be complicated due to a cost burden
on both the patient and the health care system. Careful but prompt examination can
help determine when imaging may be the necessary next step. Unfortunately, even
after multiple exams, labs, and imaging, the patient may still be left with a poor
prognosis with ineffective treatment options.
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